Author:
Iwakiri Rika,Ohta Masatsugu,Mikoshiba Michiaki,Tsutsumi Hisashi,Kumakawa Toshiro,Mori Mayumi
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Brinker M. Estimate of overall treatment results in acute nonlym- phocytic leukemia based on age specific rates of incidence and of complete remission.Cancer Treat Rep. 1985;69:5–11.
2. Whitely R, Hannah P, Holmes F. Survival in acute leukemia in elderly patients. No improvement in the 1980s.J Am Geriatr Soc. 1990;38:527–530.
3. Arumugan M. Acute myeloblastic leukemia in the elderly: biology, prognostic factors and treatment.Int J Hematol. 1998;68:235–243.
4. Heyll A, Aul C, Gogolin F, et al. Results of combination-dose cyto- sine arabinoside and idarubicin in elderly patients with acute myeloid leukemia.Ann Hematol. 1994;68:279–283.
5. Liu Yin JA, Johnson PR, Davies JM, Flanagan NG, Gorst DW, Lewis MJ. Mitozantrone and cytosine arabinoside as first-line therapy in elderly patients with acute myeloid leukemia.Br J Haema-tol. 1991;79:415–420.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献